| 36454217 | A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms. | G3 (Bethesda) | 2023 |
| 37905142 | Interactions between ploidy and resource availability shape clonal interference at initiation and recurrence of glioblastoma. | bioRxiv | 2023 |
| 37802604 | Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients. | J Immunother Cancer | 2023 |
| 37978271 | Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy. | Sci Rep | 2023 |
| 37095442 | Fast all versus all genotype comparison using DNA/RNA sequencing data: method and workflow. | BMC Bioinformatics | 2023 |
| 37185232 | Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma. | J Immunother Cancer | 2023 |
| 36454217 | A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms. | G3 (Bethesda) | 2023 |
| 37802604 | Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients. | J Immunother Cancer | 2023 |
| 37905142 | Interactions between ploidy and resource availability shape clonal interference at initiation and recurrence of glioblastoma. | bioRxiv | 2023 |
| 37978271 | Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy. | Sci Rep | 2023 |
| 37185232 | Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma. | J Immunother Cancer | 2023 |
| 37095442 | Fast all versus all genotype comparison using DNA/RNA sequencing data: method and workflow. | BMC Bioinformatics | 2023 |
| 33994165 | Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma. | Eur Urol Focus | 2022 |
| 36092893 | Evolutionary selection identifies critical immune-relevant genes in lung cancer subtypes. | Front Genet | 2022 |
| 35500227 | Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma. | Blood Adv | 2022 |
| 36215121 | Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma. | Clin Cancer Res | 2022 |
| 36139469 | Drepmel-A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment. | Cells | 2022 |
| 35987136 | Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity. | Mol Immunol | 2022 |
| 35718636 | Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma. | Eur Urol | 2022 |
| 36612014 | Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes. | Cancers (Basel) | 2022 |
| 33994165 | Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma. | Eur Urol Focus | 2022 |
| 35289298 | The Radiosensitivity Index Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated With Susceptibility to Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2022 |
| 35247927 | Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy. | Clin Cancer Res | 2022 |
| 35032707 | Mitochondrial DNA sequence variation and risk of glioma. | Mitochondrion | 2022 |
| 35031572 | Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma. | Cancer Res | 2022 |
| 34965383 | Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer. | Am J Hum Genet | 2022 |
| 35500227 | Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma. | Blood Adv | 2022 |
| 35718636 | Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma. | Eur Urol | 2022 |
| 36612014 | Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes. | Cancers (Basel) | 2022 |
| 36215121 | Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma. | Clin Cancer Res | 2022 |
| 36139469 | Drepmel-A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment. | Cells | 2022 |
| 35987136 | Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity. | Mol Immunol | 2022 |
| 36092893 | Evolutionary selection identifies critical immune-relevant genes in lung cancer subtypes. | Front Genet | 2022 |
| 35289298 | The Radiosensitivity Index Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated With Susceptibility to Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2022 |
| 35247927 | Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy. | Clin Cancer Res | 2022 |
| 35032707 | Mitochondrial DNA sequence variation and risk of glioma. | Mitochondrion | 2022 |
| 35031572 | Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma. | Cancer Res | 2022 |
| 34965383 | Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer. | Am J Hum Genet | 2022 |
| 32926368 | Managing a Large-Scale Multiomics Project: A Team Science Case Study in Proteogenomics. | Methods Mol Biol | 2021 |
| 31901438 | Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy. | Eur Urol Focus | 2021 |
| 33671939 | The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer. | Cancers (Basel) | 2021 |
| 33989014 | Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt Experience. | JCO Clin Cancer Inform | 2021 |
| 34095711 | Integrating Somatic and Germline Next-Generation Sequencing Into Routine Clinical Oncology Practice. | JCO Precis Oncol | 2021 |
| 34250383 | Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in <i>KRAS</i> Wild-Type Pancreatic Cancer. | JCO Precis Oncol | 2021 |
| 33978681 | A Mutational Survey of Acral Nevi. | JAMA Dermatol | 2021 |
| 33037322 | Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas. | Lab Invest | 2021 |
| 32926368 | Managing a Large-Scale Multiomics Project: A Team Science Case Study in Proteogenomics. | Methods Mol Biol | 2021 |
| 33346915 | Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response. | Clin Exp Immunol | 2021 |
| 34793338 | Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma. | JCI Insight | 2021 |
| 34619428 | Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability. | Neoplasia | 2021 |